TMCnet News
Finalists of the 2019 Reaxys® PhD Prize AnnouncedLONDON, July 30, 2019 /PRNewswire/ -- Elsevier, the global information analytics company specializing in science and health, today announced the 45 finalists for the 2019 Reaxys PhD Prize.  Launched in 2010, the Reaxys PhD Prize celebrates innovative and rigorous research by ambitious young chemists. This year's competition maintained the high standards of previous years. The Review Committee have rigorously examined over 360 entries from around the globe to arrive at the 45 finalists. "We are extremely happy to see the Reaxys PhD Prize established again," said Dr. Friedrich Kroll, co-organizer of the competition. "It is so important that young innovative researchers of different disciplines are gathering to celebrate their achievements, are supported in establishing networks to address current scientific challenges—often solvable by working across disciplines." The 45 finalists are invited to the Reaxys PhD Prize Symposium that will be held on October 3 and 4, 2019, in Amsterdam, the Netherlands. This celebratory gathering includes special events, poster sessions for finalists to showcase their research, keynote presentations and a gala dinner. It is also a great opportunity to network with fellow finalists and international leaders in chemistry. During the Reaxys Prize Symposium the ten short-listed finalists will give oral presentations of their research. From these presentations, the Reaxys Advisory Board will select the three winners of the 2019 Reaxys PhD Prize. The winners will be announced at the gala dinner on the final evening of the Symposium. "This year more than 360 submissions were evaluated by over 200 international chemists from across academia and industry," said Professor Li-Zhu Wu, Director of the Supramolecular Photochemistry Lab at the Chinese Academy of Sciences and one of the Prize coordinators. "The PhD Prize is a perfect starting point to build relationships and to solve interdisciplinary problems in science and the environment." The finalists receive lifelong membership in the Reaxys Prize Club, an exclusive international network of chemists from all research areas and career paths. Members also receive unlimited access to Elsevier's Reaxys platform and Reaxys Medicinal cheistry. This year's finalists and their PhD institutions are:
Find out more about the Reaxys PhD Prize. About Elsevier Elsevier is a global information analytics business that helps scientists and clinicians to find new answers, reshape human knowledge, and tackle the most urgent human crises. For 140 years, we have partnered with the research world to curate and verify scientific knowledge. Today, we're committed to bringing that rigor to a new generation of platforms. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, 39,000 e-book titles and many iconic reference works, including Gray's Anatomy. Elsevier is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. www.elsevier.com Media contact Jonathan Davis, Communications Officer
SOURCE Elsevier 
|
View original content: